Medical syringe is seen with Moderna company logo displayed on a screen in the background in this illustration photo taken in Poland.

Jakub Porzycki | NurPhoto | Getty Images

Moderna is charging between $32 to $37 per dose for its coronavirus vaccine for some customers, under cheaper “pandemic pricing,” the company said Wednesday.

The Cambridge, Massachusetts-based company is currently in discussion for larger volume agreements that will have a lower price, Moderna CEO Stephane Bancel said on a conference call discussing the company’s second-quarter financial results. 

“We are working with governments around the world and others to ensure a vaccine is accessible regardless of ability to pay,” he said.

Moderna defines a small order of its vaccine as “in the millions,” he said. The price Moderna is charging for small orders is higher than the $19.50 per dose agreed to by U.S. drugmaker Pfizer and German biotech BioNTech in a deal with the U.S. government.

The comments came after the company reported a fivefold increase in second-quarter revenue.

Moderna said it has begun talks with multiple countries to supply its potential coronavirus vaccine, called mRNA-1273, and has already received about $400 million in deposits as of July 31. Last week, the company started a phase three trial testing how safe and effective it is on 30,000 people with results expected as early as October. The company said it expects to complete enrollment for its phase three trial in September.

This is a developing story. Please check back for updates.